# Earlier de-isolation of SARS-CoV-2-infected ICU patients using a novel viability PCR: a prospective cohort study

**Authors:** Una Vojinović, Tom Schoenmakers, Ruben Deneer, Mathie P.G. Leers, Frank van Rosmalen, Stefan H. M. Gorissen, Wilhelmine P. H. G. Verboeket-van de Venne, Walther N. K. A. van Mook, Bas C. T. van Bussel, Paul Savelkoul, Inge H. M. van Loo, Petra F. G. Wolffs

PMC · DOI: 10.1128/spectrum.01140-25 · Microbiology Spectrum · 2025-12-05

## TL;DR

This study shows that a new PCR method can detect when ICU patients with COVID-19 are no longer infectious, allowing earlier de-isolation.

## Contribution

A viability PCR method was developed and tested to detect only intact SARS-CoV-2 viruses, enabling earlier de-isolation decisions.

## Key findings

- Viability PCR became negative 2.4 days earlier than conventional PCR in ICU patients.
- The method detects only intact infectious viruses, not RNA remnants.
- Earlier de-isolation could reduce ICU isolation time and improve diagnostics.

## Abstract

Intensive care unit (ICU) patients with COVID-19 are isolated until two subsequent SARS-CoV-2 PCR tests have become negative. The question is whether the viral RNA detected here represents intact or compromised viral particles. A viability PCR method detects only intact infectious viruses and disregards RNA from incomplete non-infectious viruses or RNA remnants. We hypothesize that the time to a negative PCR is shorter using the viability PCR compared to conventional SARS-CoV-2 PCR. Patients admitted to the ICU in the Maastricht University Medical Center within an ongoing prospective cohort were included, and respiratory samples were collected three times weekly. Samples were aliquoted for viability PCR into two aliquots, one of which was treated with propidium monoazide (PMA) to eliminate incomplete viruses. The PMA-untreated sample corresponded to the traditional SARS-CoV-2 PCR used in routine diagnostics. A mean time difference between viability and conventional PCR was estimated, assuming a negative binomial distribution. One hundred two ICU patients were included in the analysis. The time to a negative PCR test result differed significantly between viability PCR and conventional PCR (Paired Prentice-Wilcoxon test P-value = 0.0001). On average, the first negative viability PCR test result occurred 2.4 days (95% CI 1.5–4.2) before the first negative conventional PCR test result. The application of a viability PCR technique for SARS-CoV-2 provided an earlier indication of the absence of intact virus, suggesting reduced infectivity, potentially enabling earlier de-isolation of ICU patients.

This study demonstrated that, within patients, on average, viability PCR became negative 2.4 days earlier than conventional PCR, indicating that viability PCR could potentially assist in de-isolating patients 2.4 days earlier. Future use of this assay could thus aid in improving routine COVID-19 diagnostics and prognostics related to the timing of de-isolation. Additionally, future development of a similar approach for other respiratory viruses could be of interest.

## Linked entities

- **Chemicals:** propidium monoazide (PubChem CID 3035529)
- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** COVID-19 (MESH:D000086382)
- **Chemicals:** PMA (MESH:C533957)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12772352/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12772352/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12772352/full.md

---
Source: https://tomesphere.com/paper/PMC12772352